Stock Report

Procter and Gamble Health Ltd Q2FY26 net profit rises to Rs. 88.54 crores

Posted On : 2025-11-05 19:37:45( TIMEZONE : IST )

Procter & Gamble Health Limited has reported Standalone financial results for the period ended September 30, 2025.

Financial Results (Q2 FY2026) - QoQ Comparison

The company has reported total income of Rs. 329.87 crores during the period ended September 30, 2025 as compared to Rs. 342.77 crores during the period ended June 30, 2025.

The company has posted net profit / (loss) of Rs. 88.54 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs. 66.18 crores for the period ended June 30, 2025.

The company has reported EPS of Rs. 53.34 for the period ended September 30, 2025 as compared to Rs. 39.87 for the period ended June 30, 2025.

Financials	Q2 FY2026	Q1 FY2026	% Change
Total Income	₹ 329.87 crs	₹342.77 crs	-3.76%
Net Profit	₹88.54 crs	₹66.18 crs	33.79%
EPS	₹53.34	₹39.87	33.78%

Financial Results (Q2 FY2026) - YoY Comparison

The company has reported total income of Rs. 329.87 crores during the period ended September 30, 2025 as compared to Rs.316.69 crores during the period ended September 30, 2024.

The company has posted net profit / (loss) of Rs.88.54 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs.82.33 crores for the period ended September 30, 2024.

The company has reported EPS of Rs.53.34 for the period ended September 30, 2025 as compared to Rs.49.6 for the period ended September 30, 2024.

Financials	Q2 FY2026	Q2 FY2025	% Change
Total Income	₹ 329.87 crs	₹316.69 crs	4.16%
Net Profit	₹88.54 crs	₹82.33 crs	7.54%
EPS	₹53.34	₹49.6	7.54%

Financial Results (Half Year Ended FY2026) - YoY Comparison

The company has reported total income of Rs.672.64 crores during the 6 Months period ended September 30, 2025 as compared to Rs.602.70 crores during the 6 Months period ended September 30, 2024.

The company has posted net profit / (loss) of Rs.154.72 crores for the 6 Months period ended September 30, 2025 as against net profit / (loss) of Rs.99.11 crores for the 6 Months period ended September 30, 2024.

The company has reported EPS of Rs.93.21 for the 6 Months period ended September 30, 2025 as compared to Rs.59.71 for the 6 Months period ended September 30, 2024.

Financials	Half Year Ended FY2026	Half Year Ended FY2025	% Change
Total Income	₹672.64 crs	₹602.70 crs	11.60%
Net Profit	₹154.72 crs	₹99.11 crs	56.11%
EPS	₹93.21	₹59.71	56.10%

Shares of Procter & Gamble Health Limited was last trading in BSE at Rs. 6057.15 as compared to the previous close of Rs. 6089.10. The total number of shares traded during the day was 388 in over 172 trades.

The stock hit an intraday high of Rs. 6125.00 and intraday low of 6019.00. The net turnover during the day was Rs. 2360367.00.